Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2019 Dec 16;7:349. doi: 10.1186/s40425-019-0830-7

Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer

Philipp Metzger 1,#, Sabrina V Kirchleitner 1,2,#, Michael Kluge 3, Lars M Koenig 1, Christine Hörth 1, Carlotta A Rambuscheck 1, Daniel Böhmer 1, Julia Ahlfeld 1, Sebastian Kobold 1, Caroline C Friedel 3, Stefan Endres 1, Max Schnurr 1,#, Peter Duewell 1,4,✉,#
PMCID: PMC6916026  PMID: 31843014

Correction to: J ImmunoTher Cancer (2019) 7:288

https://doi.org/10.1186/s40425-019-0778-7

Following publication of the original article [1], the authors have reported that Fig. 2 and Additional file 1: Figure S1, S2 partially show red scripts.

Fig. 2.

Fig. 2

Poly(I:C)c reduces tumor mass in PDAC concomitant with enhanced T cell activation and reduced suppressive capacity of MDSC. Mice with orthotopic T110299 tumors were treated with poly(I:C)c twice prior to sacrifice at day 21 after tumor induction. a Tumor weights, tumor cell MHC-I expression and (b) serum cytokine levels. c Frequencies of MDSC populations in spleen and tumor of untreated and poly(I:C)c-treated mice. d Surface expression profiles of PD-L1 on MDSC subsets. e Frequencies of T cell populations in spleen and tumor of untreated and poly(I:C)c-treated mice. f-g CD69 and PD-1 surface expression of splenic and tumor-resident T cells. h Representative data of IFN-γ secretion in MDSC / T cell co-cultures, at a ratio of 1:1, following anti-CD3/anti-CD28 mAb-coated beads stimulation for 72 h. i Splenic T cells and MDSC from spleens and tumors of untreated or poly(I:C)c-treated tumor-bearing mice were isolated and co-cultured with CFSE-labeled T cells in increasing effector (E; MDSC) to target (T; T cell) ratios (E:T) of 0.25:1, 0.5:1 and 1:1 in the presence of anti-CD3/anti-CD28 mAb-coated beads. After 72 h CFSE dilution of CD4+ and CD8+ T cells was assessed. a-f Data ± SEM is shown for n = 5 to 8 mice per group. g-h Representative graph of three independent experiments. Data± SEM for n = 2 mice per group,unpaired two-sided students t test (*p < 0.05; **p < 0.01)

In Fig. 2:

  • A: Red font “MHC-I (MFI x 103)” should change to black font;

  • C: Red font “0.07” and “M-MDSC” should change to black font.

In Additional file 1: Figure S1, S2:

  • S1: Red font “Spleen” and “Tumor” should change to black font;

  • S2: Red font “C”, “D”, “E”, “F”, “G”, “H” should change to black font.

The correct version of the figures can be found below.

The corrections have been implemented in the original article as well.

We apologize for the inconvenience.

Supplementary information

40425_2019_830_MOESM1_ESM.pdf (1.4MB, pdf)

Additional file 1: Figure S1.. Gating strategy for the identification of MDSC populations. Figure S2. Poly(I:C)c reduces macrophage frequency and activates macrophages, cDC, B and NK cells. Figure S3. Poly(I:C)c triggers transcriptional reprogramming of MDSC. Figure S4. Significantly regulated genes in PMN- and M-MDSC upon poly(I:C)c therapy.

Footnotes

The original version of this article was revised: the authors have reported that Figure 2 and S2 partially show red scripts.

Philipp Metzger and Sabrina V. Kirchleitner contributed equally to this work.

Max Schnurr and Peter Duewell contributed equally to this work.

Supplementary information

Supplementary information accompanies this paper at 10.1186/s40425-019-0830-7.

Reference

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

40425_2019_830_MOESM1_ESM.pdf (1.4MB, pdf)

Additional file 1: Figure S1.. Gating strategy for the identification of MDSC populations. Figure S2. Poly(I:C)c reduces macrophage frequency and activates macrophages, cDC, B and NK cells. Figure S3. Poly(I:C)c triggers transcriptional reprogramming of MDSC. Figure S4. Significantly regulated genes in PMN- and M-MDSC upon poly(I:C)c therapy.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES